The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 17, 2022

Filed:

Jul. 26, 2016
Applicants:

The Regents of the University of California, Oakland, CA (US);

The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone, San Francisco, CA (US);

Inventors:

Matthias Hebrok, Belmont, CA (US);

Holger Andreas Russ, San Francisco, CA (US);

Sheng Ding, Orinda, CA (US);

Saiyong Zhu, San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/071 (2010.01); A61K 35/39 (2015.01); A01K 67/027 (2006.01); A61P 3/10 (2006.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0677 (2013.01); A01K 67/0271 (2013.01); A61K 35/39 (2013.01); A61P 3/10 (2018.01); C12N 5/0676 (2013.01); C12N 5/0678 (2013.01); A61K 35/00 (2013.01); C12N 2500/22 (2013.01); C12N 2500/33 (2013.01); C12N 2500/38 (2013.01); C12N 2501/11 (2013.01); C12N 2501/117 (2013.01); C12N 2501/155 (2013.01); C12N 2501/375 (2013.01); C12N 2501/395 (2013.01); C12N 2501/727 (2013.01); C12N 2501/91 (2013.01); C12N 2501/999 (2013.01); C12N 2506/02 (2013.01); C12N 2506/22 (2013.01); C12N 2513/00 (2013.01);
Abstract

Compositions and methods of producing mammalian cell populations that include a high proportion of pancreatic beta cells are described herein. Such cell populations are useful for treatment of diabetes. Also provided are materials and methods for the direct differentiation of stem cells, such as embryonic stem cells, into functional pancreatic beta cells. The disclosure provides the benefit of direct differentiation, which results in the production of functional pancreatic beta cells efficiently and at low cost.


Find Patent Forward Citations

Loading…